CORRECTION OF ELECTROLYTE DISTURBANCES IN PATIENTS WITH BRONCHIAL ASTHMA
Keywords:
bronchial asthma, electrolyte disturbances, magnesium, potassium, sodium, calcium, spirometryAbstract
Objective of the study: to identify electrolyte disturbances in patients with chronic stable asthma and patients with exacerbated asthma, and to assess the relationship between serum electrolyte levels, pulmonary function parameters, and taken medications. Methodology: TMA-based prospective crossover study. Department: pulmonology department of the 1st clinic of TMA. Material and methods of research: 100 patients with bronchial asthma were studied. The patients were divided into two groups: group I included 50 patients with chronic stable asthma; in group II, which included 50 patients with acute exacerbation of severe asthma. Findings included gender, age, medication, clinical examination, serum electrolyte levels (Na, K, Ca, Mg), and plain chest X-ray. A spirometer was used to assess lung function in accordance with the ATS / ERS standards. Conclusion: Hypomagnesemia and hypocalcemia were found to be the two most common electrolyte disturbances in patients with chronic stable asthma as well as in patients with exacerbated asthma. The drugs used to treat chronic asthma patients have also been found to have an effect on electrolyte levels.
References
Sharipova N.S. Healthy lifestyle measures in the prevention of bronchial asthma. forecasting of bronchial asthma risk factors and systematic approach to its prevention (in the case of Bukhara region) 2014 Bukhara State Medical Institute. (in Uzb)
Aubier M., D. Murciano, Y. Lecocguic, et al, Effects of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure, N. Engl. J. Med. 313 (2015) 420–424.
Bateman E.D., S.S. Hurd, P.J. Barnes, et al, Global strategy for asthma management and prevention: GINA executive summary, Eur. Respir. J. 31 (2018) 143–178.
Bodenhamer J., R. Bergstrom, D. Brown, et al, Frequently nebulized b-agonists for asthma: effects on serum electrolytes, Ann. Emerg. Med. 21 (2012) 1337–1342.
Bohuon C., Magnesium liquicolor, Clin. Chim. Acta 7 (2015) 811–817.
Carey O., C. Locke, J. Cookson, Effects of alterations of dietary sodium on the severity of asthma in men, Thorax 48 (2013) 714–718.
Chaiwat B., C. Poonkasem, Serum magnesium levels in acute severe asthma, Chiang Mai. Med. Bull. 40 (1) (2011) 1–5.
Crane J., C.D. Burgess, A.N. Graham, et al, Hypokalemia and electrocardiographic effects of aminophylline and salbutamol in obstructive airway disease, N. Z. Med. J. 100 (2017) 309–311.
Devereux G. Session 1: allergic disease: nutrition as a potential determinant of asthma, Proc. Neutr. Soc. 69 (1) (2011 Feb) 1–10.
Emad H., Ibrahim, Ahmed Yousery. Electrolyte disturbance; the effect of different forms of b-stimulants, Chest 128 (4) (2015 November) 246.
Gustafson T., K. Boman, L. Rosenhall, et al, Skeletal muscle magnesium and potassium in asthmatics treated with oral beta 2-agonists, Eur. Respir. J. 9 (2016) 237–240.
He F.J., G.A. MacGregor, Reducing population salt intake worldwide: from evidence to implementation, Prog. Cardiovasc. Dis. 52 (5) (2012) 363–382.
Kassimi M.A., A. Kawthar, A.S. Khan, et al, Hypokalemia in acute asthma in western region of Saudi Arabia, Saudi Med. J. 11 (2011) 130–133.
Khosrow A., R.G. Hamid, Blood serum magnesium values in chronic stable asthmatic patients: a case-control study, Tanaffos 4 (13) (2015) 27–32.
Lange N.E., A. Litonjua, C.M. Hawrylowicz, S. Weiss, Vitamin D, the immune system and asthma, Expert Rev. Clin. Immunol.5 (6) (2019) 693–702.
Mickleborough T., R. Gotshall, J. Rhodes, et al, Elevating dietary salt exacerbates hyperpnea-induced airway obstruction in guinea pigs, J. Appl. Physiol. 91 (2011) 1061–1066.
Mickleborough T.D. Salt intake, asthma, and exercise-induced bronchoconstriction, Phys. Sports Med. 38 (1) (2013 Apr) 118–131. Electrolyte disturbances
Miller M.R., V. Hankinson, F. Brusasco, et al, Standardisation of spirometry, Eur. Respir. J. 26 (2015) 319–338.
Omer S.B., Electrolyte disturbances in patients with chronic, stable asthma, Chest 120 (2011) 431–436.
Philips P.J., A.E. Vedig, P.L. Jones, et al, Metabolic and cardiovascular side effects of the b2-adrenoceptor agonists salbutamol and rimiterol, Br. J. Clin. Pharmacol. 9 (2011) 483–491.
Prince R., K. Monk, G. Kent, et al, Effects of theophylline and salbutamol on phosphate and calcium metabolism in normal subjects, Miner. Electrolyte Metab. 14 (2012) 262–265.
Randell J., A. Saarinen, M. Walamies, et al, Safety of formoterol after cumulative dosing via Easyhaler and Aerolizer, Respir. Med. 99 (12) (2015) 1485–1493, Epub 2005 Oct 11.
Spivey W., E. Skobeloff, R. Levin, Effect of magnesium chloride on rabbit bronchial smooth muscle, Ann. Emerg. Med. 19 (2011) 1107–1112.
Shakhanova Sh.Sh., Abdurakhmonov J.A., Rakhimov, N.M.. (2023). Targeted therapy in the palliative treatment of platinum-resistant recurrent ovarian cancer complicated by ascites. The American Journal of Medical Sciences and Pharmaceutical Research, 5(08), 77–81.
Ukena D., L. Fishman, W. Niebling, Bronchial asthma: diagnosis and long-term treatment in adults, Dtsch. Arztebl. Int. 105 (21) (2011) 385–394.
Weglicki W., B. Dickens, T. Wagner, et al, Immunoregulation by neuropeptides in magnesium deficiency: ex-vivo effect of enhanced substance-P production on circulating T lymphocytes from magnesium-deficient mice, Magnes. Res. 9 (2011) 3–11.
Статья поступила в редакцию 22.10.2023; одобрена после рецензирования 21.12.2023; принята к публикации 25.12.2023.
The article was submitted 22.10.2023; approved after reviewing 21.12.2023; accepted for publication 25.12.2023.
Информация об авторах:
Саидова Шахноза Ариповна-кандидат медицинских наук, старший преподаватель кафедры клинической фармакологии Ташкентской медицинской академии. ShahnozaAripovna@gmail.com, https://orcid.org/0000-0001-6168-714X
Якубов Абдужалол Вахабович-доктора медицинских наук, профессора, заведующего кафедрой клинической фармакологии Ташкентской медицинской академии. abdujalolyakubov@gmail.com, https://orcid.org/0000-0003-4599-2130
Пулатова Наргиза Ихсановна -доктора медицинских наук, доцента кафедры клинической фармакологии Ташкентской медицинской академии. nargiza.pulatova1984@gmail.com, https://orcid.org/0000-0001-7178-6416
Пулатова Дурдона Бахадировна-кандидат медицинских наук, доцент кафедры клинической фармакологии Ташкентской медицинской академии. d.b.pulatova@gmail.com, https://orcid.org/0000-0003-3438-4332
Абдусаматова Дилорам Зиявуддиновна-кандидата медицинских наук, заведующая кафедрой клинической фармакологии Ташкентской медицинской академии. qituvchisid.z.abdusamatova@gmail.com, https://orcid.org/0000-0001-9231-3992
Источники финансирования: Работа не имела специального финансирования.
Конфликт интересов: Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Вклад авторов:
Cаидова Ш.А.— идеологическая концепция работы, написание текста; редактирование статьи;
Якубов А.В.. — идеологическая концепция работы, сбор и анализ источников литературы,
Пулатова Н.И.- написание текста; редактирование статьи;
Пулатова Д.Б.-— сбор и анализ источников литературы, написание текста.
Абдусаматова Д.З.- написание текста; редактирование статьи;
Information about the authors:
Shakhnoza Aripovna Saidova is a Candidate of Medical Sciences, senior lecturer at the Department of Clinical Pharmacology of the Tashkent Medical Academy. ShahnozaAripovna@gmail.com, https://orcid.org/0000-0001-6168-714X
Yakubov Abduzhalol Vakhabovich is a Doctor of Medical Sciences, Professor, Head of the Department of Clinical Pharmacology at the Tashkent Medical Academy. abdujalolyakubov@gmail.com, https://orcid.org/0000-0003-4599-2130
Pulatova Nargiza Ihsanovna is a Doctor of Medical Sciences, Associate professor of the Department of Clinical Pharmacology at the Tashkent Medical Academy. nargiza.pulatova1984@gmail.com, https://orcid.org/0000-0001-7178-6416
Pulatova Durdona Bahadirovna is a candidate of Medical Sciences, Associate Professor of the Department of Clinical Pharmacology at the Tashkent Medical Academy. d.b.pulatova@gmail.com , https://orcid.org/0000-0003-3438-4332
Abdusamatova Diloram Ziyavuddinovna-Candidate of Medical Sciences, Head of the Department of Clinical Pharmacology of the Tashkent Medical Academy. qituvchisid.z.abdusamatova@gmail.com, https://orcid.org/0000-0001-9231-3992
Sources of funding: The work did not receive any specific funding.
Conflict of interest: The authors declare no explicit or potential conflicts of interest associated with the publication of this article.
Contribution of the authors:
Saidova Sh.A.— ideological concept of the work, writing the text; editing the article;
Yakubov A.V. — .— ideological concept of the work, collection and analysis of literature sources;
Pulatova N.I.- writing the text; editing the article;
Pulatova D.B..- collection and analysis of literature sources, writing the text.
Abdusamatova D.Z.- writing the text; editing the article;
